📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The CDC42 effector protein MRCKß autophosphorylates on Threonine 1108. (2020)

First Author: Unbekandt M

Attributed to: Development of a novel drug targeting MRCK and ROCKII for the treatment of invasive and/or metastatic cancer. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/21541248.2018.1564472

PubMed Identifier: 30667325

Publication URI: http://europepmc.org/abstract/MED/30667325

Type: Journal Article/Review

Volume: 11

Parent Publication: Small GTPases

Issue: 6

ISSN: 2154-1248